Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer

Fig. 5

(A) Forest plots of the relationship between Gustave Roussy Immune Score and progression-free survival (I2 = 23.6%, p = 0.269; HR: 1.78, 95% CI: 1.35–2.34, p < 0.001). (B) Sensitivity analysis of the association between the Gustave Roussy Immune Score and progression-free survival. HR, hazard ratio; CL, confidence interval

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us